Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.

Published

Journal Article (Review)

Human immunoglobulin prepared for intravenous administration (IGIV) has a number of important uses in the treatment of disease. Some of these are in diseases for which acceptable treatment alternatives do not exist. In this review we have evaluated the evidence underlying a wide variety of IGIV uses and make specific recommendations on the basis of these data. Given the potential risks and inherent scarcity of IGIV, careful consideration of the indications for and administration of IGIV is warranted.

Full Text

Duke Authors

Cited Authors

  • Orange, JS; Hossny, EM; Weiler, CR; Ballow, M; Berger, M; Bonilla, FA; Buckley, R; Chinen, J; El-Gamal, Y; Mazer, BD; Nelson, RP; Patel, DD; Secord, E; Sorensen, RU; Wasserman, RL; Cunningham-Rundles, C; Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology,

Published Date

  • April 2006

Published In

Volume / Issue

  • 117 / 4 Suppl

Start / End Page

  • S525 - S553

PubMed ID

  • 16580469

Pubmed Central ID

  • 16580469

Electronic International Standard Serial Number (EISSN)

  • 1097-6825

International Standard Serial Number (ISSN)

  • 0091-6749

Digital Object Identifier (DOI)

  • 10.1016/j.jaci.2006.01.015

Language

  • eng